Samsara BioCapital, LLC

Q2 2023 13F Holdings Report, Stock Holdings

Signature - Title
Miran Ahmad - Chief Financial Officer
Location
Palo Alto, CA
Holdings as of
30 Jun 2023
Value $
$570M
Num holdings
47
Date filed
14 Aug 2023, 16:58
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included KDNY, MLYS, SLRN, SRRK, and GRPH.
Previous filing
Q1 2023 - 14 Aug 2023
Next filing
Q3 2023 - 14 Nov 2023
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2023 Q2 compared to 2023 Q1 - Restatement by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Miran Ahmad Chief Financial Officer Palo Alto, California 14 Aug 2023